Oligomeric Amyloid-β Peptide on Sialylic Lewisx–Selectin Bonding at Cerebral Endothelial Surface

Sholpan Askarova, Grace Y. Sun, Gerald A. Meininger, James Lee

Abstract


Introduction: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder, which affects approximately 10% of the population aged 65 and 40% of people over the age 80. Currently, AD is on the list of diseases with no effective treatment. Thus, the study of molecular and cellular mechanisms of AD progression is of high scientific and practical importance. In fact, dysfunction of the blood-brain barrier (BBB) plays an important role in the onset and progression of the disease. Increased deposition of amyloid b peptide (Aβ) in cerebral vasculature and enhanced transmigration of monocytes across the BBB are frequently observed in AD brains and are some of the pathological hallmarks of the diseases. Since the transmigration of monocytes across the BBB is both a mechanical and a biochemical process, the expression of adhesion molecules and mechanical properties of endothelial cells are the critical factors that require investigation.

Methods: Because of recent advances in the biological applications of atomic force microscopy (AFM), we applied AFM with cantilever tips bio-functionalized by sLex in combination with the advanced immunofluorescent microscopy (QIM) to study the direct effects of Aβ42 oligomers on the selectins expression, actin polymerization, and cellular mechanical and adhesion properties in cerebral endothelial cells (mouse bEnd3 line and primary human CECs) and find a possible way to attenuate these effects. 

Results: QIM results showed that Aβ42 increased the expressions of P-selectin on the cell surface and enhanced actin polymerization. Consistent with our QIM results, AFM data showed that Aβ42 increased the probability of cell adhesion with sLex-coated cantilever and cell stiffness. These effects were counteracted by lovstatin, a cholesterol-lowering drug.  Surprisingly, the apparent rupture force of sLex-selectin bonding was significantly lower after treatment with Aβ42, as compared with the control (i.e. no treatment). Similar results were also obtained when cells were treated with latruculin A (F-actin-disrupting drug). These results suggest that the decrease in the apparent rupture force of sLex-selectin bonding is the consequence of the dissociation of adhesion between the cytoskeleton and the bilayer membrane induced by Aβ42. The major causes of excess mortality in the first group were neoplams (30.6%), hypertension (23.8%), and myocardial infarction (22.6%). The effects of radiation influenced mortality in the second group were 2-2.5 times lower than the first group. 

Conclusion: The studies of the effects of Aβ42 on the adhesion properties of cerebral endothelial cells and how pharmacological agents (e.g. statin) counteract these effects should prove to provide insights into the mechanism of inflammation in Alzheimer’s brains and the design of therapeutic treatments of the disease.


Keywords


Alzheimer’s disease; statins; brain inflamation; treatment

Full Text:

PDF


DOI: https://doi.org/10.5195/cajgh.2014.150

Refbacks

  • There are currently no refbacks.




Copyright (c) 2014 Sholpan Askarova, Grace Y. Sun, Gerald A. Meininger, James Lee

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.